Serotonergic and Dopaminergic Lesions Underlying Parkinsonian Neuropsychiatric Signs

Dopamine Transporter, Age, and Motor Complications in Parkinson's Disease: A Clinical and Single‐Photon Emission Computed Tomography Study

(2020) Giovanni Palermo et al.   MOVEMENT DISORDERS

Early limbic microstructural alterations in apathy and depression in de novo Parkinson's disease

(2019) Stéphane Prange et al.   MOVEMENT DISORDERS

Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study

(2019) Heather Wilson et al.   LANCET NEUROLOGY

Preserved Serotonergic Activity in Early-Onset Parkinson’s Disease

(2019) Hee Kyung Park et al.   CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

Investigation of serotonergic Parkinson's disease-related covariance pattern using [ 11 C]-DASB/PET

(2018) Jessie Fanglu Fu et al.   NeuroImage-Clinical

Disturbance of approach-avoidance behaviors in non-human primates by stimulation of the limbic territories of basal ganglia and anterior insula

(2018) Yosuke Saga et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Age and time course of long-term motor and nonmotor complications in Parkinson disease

(2018) Stéphane Prange et al.   NEUROLOGY

Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson’s disease

(2017) Han Soo Yoo et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies

(2017) Daryl J Wile et al.   LANCET NEUROLOGY

The prominent role of serotonergic degeneration in apathy, anxiety and depression inde novoParkinson’s disease

(2016) Audrey Maillet et al.   BRAIN

Serotonin-to-dopamine transporter ratios in Parkinson disease

(2016) Andreas-Antonios Roussakis et al.   NEUROLOGY

Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate

(2015) Maude Beaudoin-Gobert et al.   BRAIN

Clinical correlates of raphe serotonergic dysfunction in early Parkinson’s disease

(2015) Zahi Qamhawi et al.   BRAIN

Parkinson's disease

(2015) Lorraine V Kalia et al.   LANCET

Putaminal dopamine turnover in de novo Parkinson disease predicts later motor complications

(2015) Matthias Löhle et al.   NEUROLOGY

Apathy in Parkinson's disease is associated with nucleus accumbens atrophy: A magnetic resonance imaging shape analysis

(2014) Nicolas Carriere et al.   MOVEMENT DISORDERS

Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease

(2011) Benedicte Ballanger et al.   MOVEMENT DISORDERS

Progression of monoaminergic dysfunction in Parkinson's disease: A longitudinal 18F-dopa PET study

(2011) Nicola Pavese et al.   NEUROIMAGE

Serotonergic Dysfunction in Parkinson's Disease and Its Relevance to Disability

(2011) Marios Politis et al.   TheScientificWorldJOURNAL

Age-specific progression of nigrostriatal dysfunction in Parkinson's disease

(2010) Raúl de la Fuente-Fernández et al.   ANNALS OF NEUROLOGY

Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation

(2010) S. Thobois et al.   BRAIN

Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction

(2010) N. Pavese et al.   BRAIN

Neuroanatomical correlates of apathy in Parkinson's disease: A magnetic resonance imaging study using voxel-based morphometry

(2010) Jennifer S.A.M. Reijnders et al.   MOVEMENT DISORDERS

Staging of serotonergic dysfunction in Parkinson's Disease: An in vivo 11C-DASB PET study

(2010) Marios Politis et al.   NEUROBIOLOGY OF DISEASE

Regional patterns of brain tissue loss associated with depression in Parkinson disease

(2010) V. S. Kostic et al.   NEUROLOGY

Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures

(2010) M. Politis et al.   NEUROLOGY

Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease

(2009) I. Boileau et al.   BRAIN

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study

(2009) T. D. L. Steeves et al.   BRAIN

Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study

(2009) R. Nandhagopal et al.   BRAIN

A follow-up study on 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease shows nonlinear progression in the putamen

(2009) Anna Brück et al.   MOVEMENT DISORDERS

Construction and validation of a dimensional scale exploring mood disorders: MAThyS (Multidimensional Assessment of Thymic States)

(2008) Chantal Henry et al.   BMC Psychiatry

Elevated serotonin transporter binding in depressed patients with Parkinson's disease: A preliminary PET study with [11C]DASB

(2008) Isabelle Boileau et al.   MOVEMENT DISORDERS

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS